Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Kefir Protects Against Mutations

12.12.2002


Scientists all over the world hunt for anti-mutagens, substances protecting against mutations. Where they can find them? It was suggested and later proved that most anti-mutagens are located in those organs and biological liquids, which are connected with the process of reproduction. The latter is the key point in the life cycle, in which genome disorders should be minimal. Anti-mutagens were found in seeds, spores, eggs, and sperm. It was also established that anti-mutagens are formed in certain bacteria. Then, microbiologists have become curious about a possibility of obtaining and using bacterial mutagens in medicine.



Among wonderful bacteria producing anti-mutagens, there are bifidobacteria and lactic-acid bacteria that are very beneficial for health. They can be already called "domestic" because of their wide application in producing various milk, meat, and special fermented foodstuffs for people and animals. Bifidobacteria are the main component of a natural microflora of the intestine and produce lactic, acetic, and butyric acids that kill pathogenic and putrefactive bacteria. The same acids are produced by lactic bacteria inhabiting fermented milk.

Experiments conducted by L.I. Vorob’eva and S.K. Abilev have shown that chemical mutagens kept in fermented milk lose their dangerous properties. Lactic-acid bacteria attack mutagens in different ways. They produce proteins-enzymes and lactic, butyric, and acetic acids, which suppress the activity of mutagens. Some lactic-acid bacteria are capable of forming chemical bounds with mutagens. Sometimes, bacterial cells act as anti-oxidants and remove free radicals.


On the basis of data obtained, the authors conclude that lactic-acid bacteria and bifidobacteria neutralize mutagens, which are dangerous for the genome, within the alimentary canal. It should be mentioned that mutagens may often act as carcinogens, i.e., cause cancer. Therefore, the bacteria and their metabolites protect not only against mutations, but also against cancer. The scientists suggest that they can also neutralize carcinogenic agents and hinder the growth of a newly formed tumour. This is proven by the experiments on rats as well as by medical observations: people who take fermented milk products are less subjected to intestine cancer.

Another valuable group of microorganisms is propionic bacteria, which are used in the production of vitamin B12, bakery, and in pharmaceutics. They live in cheese and milk, and some species - on the skin. The scientists have established that these also act against mutagens.

Protective properties are also found in bacterium enterococcus that inhabits the intestine. It produces proteins that make DNA less damageable.

Fortunately, the anti-mutagenic properties of bacteria are universal. So, using bacteria, people can obtain anti-mutagenic and anti-carcinogenic agents, which may become a basis for creating new food supplements and drugs. And including kefir, yogurt, and other fermented milk products in daily menu is very advisable for everyone.

Nadejda Markina | alfa
Further information:
http://www.informnauka.ru/eng/2002/2002-12-11-02_268_e.htm

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

German-British Research project for even more climate protection in the rail industry

28.05.2020 | Transportation and Logistics

A special elemental magic

28.05.2020 | Physics and Astronomy

Skoltech scientists get a sneak peek of a key process in battery 'life'

28.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>